Back to Search
Start Over
Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022
Treatment of Mpox with Suspected Tecovirimat Resistance in Immunocompromised Patient, United States, 2022
- Source :
- Emerging Infectious Diseases, Vol 29, Iss 12, Pp 2520-2523 (2023)
- Publication Year :
- 2023
- Publisher :
- Centers for Disease Control and Prevention, 2023.
-
Abstract
- Reports of tecovirimat-resistant mpox have emerged after widespread use of antiviral therapy during the 2022 mpox outbreak. Optimal management of patients with persistent infection with or without suspected resistance is yet to be established. We report a successfully treated case of severe mpox in California, USA, that had suspected tecovirimat resistance.
Details
- Language :
- English
- ISSN :
- 10806040 and 10806059
- Volume :
- 29
- Issue :
- 12
- Database :
- Directory of Open Access Journals
- Journal :
- Emerging Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.1338baf33b46a88e0a7a897c9a9ece
- Document Type :
- article
- Full Text :
- https://doi.org/10.3201/eid2912.230849